HK1207963A1 - Oral pharmaceutical formulation of bcs class iii molecules bsc iii - Google Patents
Oral pharmaceutical formulation of bcs class iii molecules bsc iiiInfo
- Publication number
- HK1207963A1 HK1207963A1 HK15108555.3A HK15108555A HK1207963A1 HK 1207963 A1 HK1207963 A1 HK 1207963A1 HK 15108555 A HK15108555 A HK 15108555A HK 1207963 A1 HK1207963 A1 HK 1207963A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- iii
- bsc
- pharmaceutical formulation
- oral pharmaceutical
- molecules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1255593A FR2991879B1 (fr) | 2012-06-14 | 2012-06-14 | Formulation pharmaceutique orale de molecules bcs de classe iii |
PCT/EP2013/062398 WO2013186370A1 (fr) | 2012-06-14 | 2013-06-14 | Formulation pharmaceutique orale de molecules bcs de classe iii |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1207963A1 true HK1207963A1 (en) | 2016-02-19 |
Family
ID=48626457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15108555.3A HK1207963A1 (en) | 2012-06-14 | 2015-09-01 | Oral pharmaceutical formulation of bcs class iii molecules bsc iii |
Country Status (6)
Country | Link |
---|---|
US (1) | US10258692B2 (xx) |
EP (1) | EP2861216B1 (xx) |
ES (1) | ES2733222T3 (xx) |
FR (1) | FR2991879B1 (xx) |
HK (1) | HK1207963A1 (xx) |
WO (1) | WO2013186370A1 (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190282500A1 (en) | 2016-09-09 | 2019-09-19 | Cutispharma, Inc. | Suspensions and diluents for metronidazole and baclofen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100784752B1 (ko) * | 2000-02-04 | 2007-12-13 | 다케다 야쿠힌 고교 가부시키가이샤 | 안정한 에멀젼 조성물 |
US20050090554A1 (en) * | 2003-09-12 | 2005-04-28 | John Devane | Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists |
CA2537029C (en) * | 2003-11-26 | 2013-03-12 | Likan Liang | Micellar systems useful for delivery of lipophilic or hydrophobic compounds |
EP1961412A1 (en) * | 2006-12-27 | 2008-08-27 | LEK Pharmaceuticals D.D. | Self-microemulsifying drug delivery systems |
US20100029771A1 (en) * | 2008-07-31 | 2010-02-04 | Olivier Ameisen | Treatment of addictive disorders |
-
2012
- 2012-06-14 FR FR1255593A patent/FR2991879B1/fr active Active
-
2013
- 2013-06-14 EP EP13729029.2A patent/EP2861216B1/fr active Active
- 2013-06-14 WO PCT/EP2013/062398 patent/WO2013186370A1/fr active Application Filing
- 2013-06-14 ES ES13729029T patent/ES2733222T3/es active Active
- 2013-06-14 US US14/407,858 patent/US10258692B2/en active Active
-
2015
- 2015-09-01 HK HK15108555.3A patent/HK1207963A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013186370A1 (fr) | 2013-12-19 |
US10258692B2 (en) | 2019-04-16 |
EP2861216A1 (fr) | 2015-04-22 |
EP2861216B1 (fr) | 2019-04-17 |
FR2991879A1 (fr) | 2013-12-20 |
ES2733222T3 (es) | 2019-11-28 |
FR2991879B1 (fr) | 2014-11-21 |
US20150165032A1 (en) | 2015-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255336A1 (zh) | 藥物製劑及其製備方法 | |
ZA201703992B (en) | Inhalable pharmaceutical compositions | |
IL252566B (en) | Pharmacy preparations and methods | |
IL233756A (en) | History of hydroxamic acid and their pharmaceutical preparations | |
IL236024A (en) | The history of benzimidazole-proline and its pharmaceutical preparations | |
HK1203812A1 (en) | Novel pharmaceutical formulations | |
EP3038465A4 (en) | Oral pharmaceutical formulation of omarigliptin | |
HK1203815A1 (en) | Pharmaceutical compositions and methods for their preparation | |
HK1199821A1 (en) | Oral pharmaceutical composition | |
HK1199822A1 (zh) | 口服給藥用醫藥組合物 | |
HK1205146A1 (en) | Pharmaceutical formulation | |
IL237139A0 (en) | Pharmaceutical compositions of memantine | |
HK1205683A1 (en) | Pharmaceutical formulation having improved stability | |
IL238059A0 (en) | History of pyrrolidine, and pharmaceutical preparations containing them | |
EP2874987A4 (en) | ALPHA AND GAMMA TRUXILLINIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
HK1207963A1 (en) | Oral pharmaceutical formulation of bcs class iii molecules bsc iii | |
GB201208315D0 (en) | Pharmaceutical methods and compositions | |
EP2884963A4 (en) | STABLE PHARMACEUTICAL FORMULATION OF CABAZITAXEL | |
GB201207064D0 (en) | Pharmaceutical compositions comprising 15-hetre and methods of using the same | |
GB201211403D0 (en) | Pharmaceutical formulations |